Arbe's Q2 Revenue Doubled to $0.7 Million - but $42M Cash Keeps the Clock Ticking

Q2 revenue improved, but revenue is still too small to quiet the funding debate

Arbe's second quarter puts the bull/bear split clearly in view. The positive read is straightforward: Q2 revenue rose to $0.7 million from $0.3 million a year ago. The caution is just as clear: that is still a small revenue base for a company that continues to spend far more than it brings in.

Arbe reported EPS of -$0.06, underscoring that the company is still operating below its means. The quarter shows the business is not standing still, but it does not yet show a self-sustaining revenue engine.

That is why the next report matters. Arbe's next earnings call is scheduled for Nov. 12, 2026. Investors will be looking for signs that this quarter was the start of a more durable sales rhythm rather than another promising preprofit phase.

Cash and backlog matter more than the headline revenue number

The setup looks better than the quarterly scoreboard suggests. Arbe says it holds about $42 million in cash, cash equivalents and short-term bank deposits. With cash burn still the key pressure point, that cushion matters: it gives Arbe more time to turn evaluations, pilots, and early shipments into repeat orders.

The operating story is also broadening beyond a single market path. In defense, Arbe signed a framework collaboration agreement covering three joint projects and has begun deliveries of radar systems directly from its production line. In robotaxi, Arbe's systems are being used in programs where vehicles have commenced on-road trials, and the company remains engaged with more prospects. That does not prove recurring revenue yet. It does suggest the technology is being tested in real operating environments, not just in a lab.

Where the bullish case can be validated

The main bullish question is conversion, not interest. If early defense deliveries, robotaxi programs, and ongoing evaluations start producing repeat business, the story can shift from technical promise toward commercial proof.

The main bearish risk is that these milestones remain lumpy and hard to model. Early deliveries can be project-based rather than recurring, and a small pipeline can stall before it becomes meaningful revenue.

What investors should watch on the next call

The next test is practical, not inspirational. On Nov. 12, 2026, investors should focus on one question: are evaluations, bids, and early shipments turning into actual orders?

Signals that would strengthen the setup

• Arbe says backlog as of June 30, 2026 amounted to $1 million. Investors need evidence that this base is growing through customer commitments, not just one-off shipments.
• In defense, the framework collaboration agreement covering three joint projects needs to start producing repeat deliveries rather than serving as a one-quarter headline.
• In robotaxi, the key question is whether active bid processes with additional robotaxi players convert into repeat shipments.
• In China, the near-term milestone is whether HiRain stays on track for production planned for the beginning of 2027.

Signals that would weaken the setup

The story weakens quickly if management talks more about process than proof. If backlog remains flat and revenue stays tiny, the cash cushion and leaner cost structure may not be enough to keep financing risk far from the foreground. In small-cap technology, dilution can arrive before the income statement looks mature.

The disciplined watchpoint is simple: don't pay for inspiration. Wait for shipped business.